Raymond James Financial Services Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-610	Closed	-$27K	–	3482
2021 Q3	$27K	Buy	+610	New	+$26.3K	﹤0.01%	3227
2020 Q2	–	Sell	-2,810	Closed	-$250K	–	2930
2020 Q1	$250K	Hold	2,810	–	–	﹤0.01%	1948
2019 Q4	$321K	Buy	2,810 +310	+12%	+$23.3K	﹤0.01%	2283
2019 Q3	$155K	Buy	2,500 +1,000	+67%	+$80K	﹤0.01%	2558
2019 Q2	$117K	Buy	1,500 +650	+76%	+$73.8K	﹤0.01%	2656
2019 Q1	$115K	Hold	850	–	–	﹤0.01%	2624
2018 Q4	$68K	Hold	850	–	–	﹤0.01%	2440
2018 Q3	$89K	Hold	850	–	–	﹤0.01%	2671
2018 Q2	$85K	Hold	850	–	–	﹤0.01%	2634
2018 Q1	$107K	Hold	850	–	–	﹤0.01%	2373
2017 Q4	$142K	Hold	850	–	–	﹤0.01%	2340
2017 Q3	$268K	Hold	850	–	–	﹤0.01%	2093
2017 Q2	$252K	Buy	850 +344	+68%	+$92K	﹤0.01%	2071
2017 Q1	$117K	Buy	+506	New	+$87.4K	﹤0.01%	2243

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Raymond James Financial Services Advisors's CALA Position: Q4 2021 in Review

Raymond James Financial Services Advisors sold out of Calithera Biosciences, Inc (CALA) in Q4 2021, closing a stake of 610 shares — an estimated $27K sold.

Raymond James Financial Services Advisors first reported a position in CALA in Q1 2017 and held it in 14 quarters. The position peaked at $321K in Q4 2019. 55 funds tracked by Wall St. Rank hold CALA as of Q4 2021.

Raymond James Financial Services Advisors reported no remaining Calithera Biosciences, Inc position as of Q4 2021 after selling out during the quarter.
Raymond James Financial Services Advisors sold 610 Calithera Biosciences, Inc shares in Q4 2021, an estimated $27K.
Raymond James Financial Services Advisors first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 14 quarters.
Raymond James Financial Services Advisors's Calithera Biosciences, Inc position peaked at $321K in Q4 2019.
55 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.